Skip to main content

Table 3 Comparison of antimicrobial therapies prescribed in the empirical and the rm-PCR-guided groups (n = 159)

From: Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia

Antibiotic treatment Routine empirical therapy (%) rm-PCR-guided therapy (%)
Beta-lactams 147 (92) 131 (82)
Third-generation cephalosporin 35 (22) 24 (15)
Piperacillin-tazobactam 29 (18) 34 (21)
Amoxicillin-clavulanate 27 (17) 25 (16)
Carbapenem 27 (17) 19 (12)
Cefepime 19 (12) 19 (12)
Amoxicillin 5 (3) 4 (3)
Ceftazidime 3 (2) 7 (4)
Cefazolin 2 (1) 6 (4)
Penicillin M 0 (0) 2 (1)
Companion molecule 79 (50) 50 (31)
Macrolide 20 (13) 4 (3)
Metronidazole 17 (11) 8 (5)
Aminoglycoside 15 (9) 19 (12)
Fluoroquinolone 8 (5) 5 (3)
Glycopeptide 6 (4) 2 (1)
Linezolide 6 (4) 8 (5)
Cotrimoxazole 7 (4) 4 (3)
Antifungal therapy 5 (3) 4 (3)
Oseltamivir 3 (2) 0
Other 4 (3) 0
  1. Results are presented as n (%)